Mountain Valley MD Holdings Inc. (20MP)
XFRA 
Summary
20MP Chart
Mountain Valley MD demonstrates commercialization progress across key sectors in 2024 update
Mountain Valley MD Holdings Inc (CSE:MVMD, OTCQB:MVMDF) (MVMD) has provided a year-end update on its 2024 business progress, focusing on commercialization efforts in nutraceuticals, agriculture, and husbandry animals/aquatic species. The company's Quicksome technology, designed to enhance the delivery and efficacy of sublingual nutraceuticals, saw significant advancements.
Mountain Valley MD shares updates from ‘transformative' six months
Mountain Valley MD Holdings Inc (CSE:MVMD, OTCQB:MVMDF) told investors the last six months have been a “truly transformative window” for the company as its technologies have been positively received. The company on Friday provided a general business update on its progress across its three core lines of business: nutraceuticals, agriculture and husbandry animals/aquatic species.
Mountain Valley MD Holdings Inc. (20MP) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Mountain Valley MD Holdings Inc. ever had a stock split?
Mountain Valley MD Holdings Inc. Profile
| Specialty Retail Industry | Consumer Discretionary Sector | Dennis Hancock CEO | XFRA Exchange | CA62430M1014 ISIN |
| CA Country | 1 Employees | 2 Mar 2020 Last Dividend | 2 Mar 2020 Last Split | - IPO Date |
Overview
Mountain Valley MD Holdings Inc. operates in the health and wellness sector through its subsidiary, Mountain Valley MD Inc. It is focused on the development, implementation, and licensing of its innovative technologies and formulations. These are aimed at enhancing the delivery and effectiveness of molecules for applications in humans and animals in various health-related areas including pain management, weight loss, energy, focus, sleep, anxiety, and more. The company is based in Concord, Canada, positioning itself as a key player in the health and wellness industry with its groundbreaking technologies.
Products and Services
- Quicksome Oral Drug Formulation and Delivery Technologies
- Quicksol Solubility Formulation Technology
- Dose Sparing Adjuvant
- Licensed Agrarius Agricultural Plant Signalling Technology
This technology focuses on enhancing the bioavailability and effectiveness of orally administered drugs and health supplements. By improving how drugs are absorbed in the body, Quicksome aims to increase the efficacy of medications and supplements, targeting issues like energy, focus, and sleep more effectively.
Quicksol addresses one of the major challenges in drug formulation: the solubility of molecules. By increasing the solubility of drugs, this technology enhances their absorption and bioavailability, making treatments for conditions like pain and anxiety more efficient.
This innovative product is designed to reduce the required dose of vaccines and drugs, thereby sparing doses while maintaining or enhancing their effectiveness. This technology has applications in both human health and animal husbandry, underscoring the company's commitment to broad-spectrum wellness solutions.
Agrarius is a technology focused on agriculture, specifically on enhancing the signals between plants to improve their growth and resilience. This licensed technology underlines Mountain Valley MD's interest in crossover technologies that benefit both human and animal wellness, along with agricultural productivity.
